Clinical efficacy and survival analysis of adjuvanttislelizumab immunotherapy after radical resection of renal cell carcinoma
SUN Zhenceng
WANG Rui
JIANG Xiaoming
FU Zhenrui
Machine-generated Keywords：
Publication Date：2022-10-20
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：5( 494-497,520 )